Repairing the Brain by SCF+G-CSF Treatment at 6 Months Postexperimental Stroke: Mechanistic Determination of the Causal Link Between Neurovascular Regeneration and Motor Functional Recovery

ASN Neuro. 2016 Aug 9;8(4):1759091416655010. doi: 10.1177/1759091416655010. Print 2016 Jun.

Abstract

Stroke, a leading cause of adult disability in the world, is a severe medical condition with limited treatment. Physical therapy, the only treatment available for stroke rehabilitation, appears to be effective within 6 months post-stroke. Here, we have mechanistically determined the efficacy of combined two hematopoietic growth factors, stem cell factor (SCF) and granulocyte-colony stimulating factor (G-CSF; SCF + G-CSF), in brain repair 6 months after cortical infarct induction in the transgenic mice carrying yellow fluorescent protein in Layer V pyramidal neurons (Thy1-YFP-H). Using a combination of live brain imaging, whole brain imaging, molecular manipulation, synaptic and vascular assessments, and motor function examination, we found that SCF + G-CSF promoted mushroom spine formation, enlarged postsynaptic membrane size, and increased postsynaptic density-95 accumulation and blood vessel density in the peri-infarct cavity cortex; and that SCF + G-CSF treatment improved motor functional recovery. The SCF + G-CSF-enhanced motor functional recovery was dependent on the synaptic and vascular regeneration in the peri-infarct cavity cortex. These data suggest that a stroke-damaged brain is repairable by SCF + G-CSF even 6 months after the lesion occurs. This study provides novel insights into the development of new restorative strategies for stroke recovery.

Keywords: G-CSF; SCF; brain repair; chronic stroke; hematopoietic growth factors; live brain imaging.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Brain / diagnostic imaging
  • Brain / drug effects*
  • Brain / pathology
  • Dendritic Spines / drug effects
  • Dendritic Spines / ultrastructure
  • Disease Models, Animal
  • Disks Large Homolog 4 Protein
  • Enzyme Inhibitors / therapeutic use
  • Functional Laterality
  • Gene Expression Regulation / drug effects
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Infarction, Middle Cerebral Artery / diagnostic imaging
  • Infarction, Middle Cerebral Artery / drug therapy*
  • Infarction, Middle Cerebral Artery / pathology
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Male
  • Membrane Proteins / metabolism
  • Mice
  • Mice, Transgenic
  • Motor Activity / drug effects*
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / ultrastructure
  • Nitriles / therapeutic use
  • Phosphopyruvate Hydratase / metabolism
  • Platelet Endothelial Cell Adhesion Molecule-1 / metabolism
  • Recovery of Function / drug effects*
  • Regeneration / drug effects*
  • Sulfones / therapeutic use
  • Transcription Factor RelA / metabolism

Substances

  • 3-(4-methylphenylsulfonyl)-2-propenenitrile
  • Disks Large Homolog 4 Protein
  • Dlg4 protein, rat
  • Enzyme Inhibitors
  • Intracellular Signaling Peptides and Proteins
  • Membrane Proteins
  • Nitriles
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Sulfones
  • Transcription Factor RelA
  • Granulocyte Colony-Stimulating Factor
  • Phosphopyruvate Hydratase